Searchable abstracts of presentations at key conferences in endocrinology

ea0035p776 | Obesity | ECE2014

Application of LC–MS and CE–MS based metabolomics to study type 2 diabetes development in lean, overweight and obese humans

Ciborowski Michal , Kretowski Adam , Adamska Edyta , Citko Anna , Waszczeniuk Magdalena , Wilk Juliusz , Golonko Anna , Pliszka Justyna , Lipinska Danuta , Goscik Joanna , Rusak Magdalena , Godzien Joanna , Barbas Coral , Gorska Maria

The risk of type 2 diabetes mellitus (T2DM) development is related to BMI, therefore this disease mainly occurs among overweight (OW) and obese (OB) people. However lean (L) individuals may also suffer from T2DM. The evolution of T2DM is a multistep process and starts with insulin resistance (IR), which may evolve into pre-diabetic state i.e.: impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT). In up to 70% of patients pre-diabetic state evolves into T2DM. ...

ea0051p050 | Pituitary and growth | BSPED2017

Siblings with 3-M Syndrome show good response to Growth Hormone (GH) therapy over a 4 year follow-up growth data

Mohamed Zainaba , Sachdev Pooja , Benson Joanna , Hastings Richard , Randell Tabitha , Denvir Louise

Introduction: 3M syndrome is a rare autosomal recessive condition that causes short stature, unusual facial features and skeletal abnormalities with normal intelligence. Mutations in CUL7, OBSL1 and CCDC8 genes have been identified as pathogenic. GH treatment outcomes for 3M syndrome appear controversial. Use of human recombinant GH for the treatment of short stature has been trialled in previous studies with some suggesting dysregulation in GH/IGF1 axis while others report no...

ea0090p163 | Pituitary and Neuroendocrinology | ECE2023

Pituitary apoplexy as the first manifestation of non-functioning pituitary neuroendocrine tumor

Dzialach Lukasz , Sobolewska Joanna , Respondek Wioleta , Wojciechowska-Luzniak Agnieszka , Witek Przemysław

Introduction: Pituitary apoplexy (PA) is a rare but potentially life-threatening complication that may occur in pituitary neuroendocrine tumors (PitNETs). Non-functioning PitNETs (NF-PitNETs), specifically macroadenomas, seem to have a higher risk of apoplexy. Case description: A 45-year-old male presented to the emergency unit with a one-week history of binocular visual deterioration (blurred vision, diplopia, visual field defect) with left-side predomi...

ea0090ep53 | Adrenal and Cardiovascular Endocrinology | ECE2023

Metabolic syndrome and primary bilateral macronodular adrenal hyperplasia

Matias Alexandra Abegao , Bouca Bruno , Gutu Olga , Prokop Joanna , Sabino Teresa , Silva-Nunes Jose

Introduction: Primary bilateral macronodular adrenal hyperplasia (PBMAH) is a rare entity. Up to 1/3 of patients with incidental bilateral adrenal nodules presents biochemical evidence of hypercortisolism responsible for obesity, diabetes mellitus (DM), arterial hypertension or dyslipidemia. Its insidious course and nonspecific signs explain the underdiagnosis of this entity.Objective: To describe the case of a patient with metabolic syndrome (MS) with h...

ea0090ep1144 | Late Breaking | ECE2023

Ectopic ACTH Syndrome in a Patient with ACTH-secreting Pancreatic Neuroendocrine Neoplasm and Focal Pituitary Lesion-Diagnostic Challenges

Sobolewska Joanna , Dzialach Lukasz , Respondek Wioleta , Wojciechowska-Luzniak Agnieszka , Witek Przemysław

Introduction: Pancreatic neuroendocrine neoplasms (Pan-NENs) account for 1-2% of all pancreatic tumors. Adrenocorticotropic hormone (ACTH)-producing PanNEN is an extremely rare neuroendocrine tumor that accounts for approximately 4-16% of ectopic ACTH-dependent Cushing’s syndrome.Clinical case : A 58-year-old female with arterial hypertension and type 2 diabetes was referred to the Endocrinology Department due to abdominal pain, muscle weakness, and...

ea0066p40 | Diabetes 4 | BSPED2019

Neonatal diabetes, Don’t sugar coat it!

Murphy Sarah , Stevenson Joanna , Mitchell Jennifer , Singh Harcharan , Fiddes Catherine , Farquharson Sarah , Whyte Karen

Background: Neonatal diabetes is an exceedingly rare condition, defined by the presence of persistent hyperglycaemia in the first months of life. It is sub-categorised into transient neonatal diabetes mellitus (TNDM) which resolves early and permanent neonatal diabetes mellitus (PNDM), which requires lifelong treatment. Transient neonatal diabetes is reported to have a global incidence of between 1/95 000–1/400 000 births. At present, there are less than 100 patients diag...

ea0063gp79 | Thyroid Autoimmune Disorders | ECE2019

The neutrophil-to-lymphocyte ratio as a novel marker in patients with thyroid-associated orbitopathy – a prelimininary study

Szydełko Joanna , Rodzik Beata , Tarach Jerzy , Matyjaszek-Matuszek Beata

Introduction: Graves’ orbitopathy (GO) is a rare autoimmune inflammatory disease occurring in 25–50% cases of Graves’ disease (GD). It is associated with poor clinical outcomes, impaired quality of life and socio-economic status. Genetic, environmental and immunological factors are considered to play a role in the pathogenesis of GO, but the effects of neutrophil, lymphocyte counts as well as neutrophil-to-lymphocyte ratio on the pathophysiology of GO are still ...

ea0063p422 | Adrenal and Neuroendocrine Tumours 2 | ECE2019

Association between new anthropometric parameters and new inflammation indicators in non-functioning adrenal incidentalomas

Kowalska Joanna , Zieleń-Zynek Iwona , Nowak Justyna , Zubelewicz-Szkodzińska Barbara

Introduction: Studies demonstrate that non-functioning adrenal incidentalomas are assosiated with increased risk of diabetes mellitus and cardiovascular diseases. Chronic inflammation plays key role in developing type 2 diabetes, as well as cardiovascular diseases.Aim: The purpose of the study was to evaluate new anthropometric parameters (BAI, LAP, VAI, BRI, ABSI, RFM) and its relationship with inflammation indicators (PLR, MPVLR, SII) among patients wi...

ea0063p455 | Adrenal and Neuroendocrine Tumours 2 | ECE2019

Can pancreatic tumor in von Hippel-Lindau syndrome be a prognostic factor?– a case study

Zwolak Agnieszka , Tywanek Ewa , Świrska Joanna , Dudzińska Marta , Tarach Jerzy

Introduction: Von Hippel-Lindau (VHL) disease is an autosomal dominant disorder characterized by formation of tumors and cysts in various organs. Renal cancer and central nervous system angiomas (whose frequencies in VHL disease are estimated for 70% and 76% respectively) are considered main prognostic factors, with renal cancer being the most common cause of death. Neuroendocrine tumors of the pancreas occur in only 10 to 20% of VHL patients and are benign in the majority of ...

ea0063p1055 | Pituitary and Neuroendocrinology 3 | ECE2019

Quality of life in patients with acromegaly assessed by AcroQoL- first application in South Poland

Przybylik-Mazurek Elwira , Krolak Monika , Joanna Marchlewska , Szlauer Anastazja , Hubalewska-Dydejczyk Alicja

Introduction: Acromegaly is a disease associated with increased secretion of growth hormone and subsequent growth of bones, soft tissues and internal organs. An important factor influencing therapeutic treatment in recent years is the patient’s quality of life associated with the disease. In patients with acromegaly, it is significantly affected by the occurrence of depression and anxiety - agents undergoing treatment, which, however, still appear undiagnosed.<p class...